Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisErythropoiesisKidney TransplantationMice, Inbred C57BLRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionHematologic NeoplasmsTreatment OutcomeGraft RejectionTime FactorsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationCell DifferentiationColony-Forming Units AssayLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseMyelodysplastic SyndromesSevere Combined ImmunodeficiencyChimeraT-LymphocytesHLA AntigensSurvival AnalysisRetrospective StudiesLung TransplantationCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionPancytopeniaSpleenNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedCarmustineOrgan TransplantationGraft vs Tumor EffectFlow CytometryGraft vs Leukemia EffectFollow-Up StudiesCytarabineLeukocyte CountSurvival RateMice, Inbred BALB CCytomegalovirus InfectionsErythroid Precursor CellsBone ResorptionErythropoietinGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalAntigens, CD34EtoposideMice, KnockoutLymphomaMultiple MyelomaGranulocytesFatal OutcomeCell SeparationHodgkin Disease